Activated human neutrophils express vascular endothelial growth factor (VEGF)

被引:133
|
作者
Webb, NJA [1 ]
Myers, CR
Watson, CJ
Bottomley, MJ
Brenchley, PEC
机构
[1] Royal Manchester Childrens Hosp, Dept Paediat Nephrol, Manchester M27 4HA, Lancs, England
[2] Manchester Royal Infirm, Manchester Renal Res Grp, Manchester M13 0JH, Lancs, England
[3] Univ Manchester, Dept Med, Manchester M13 0JH, Lancs, England
基金
英国惠康基金;
关键词
VEGF; VPF; neutrophils; immunoassay;
D O I
10.1006/cyto.1997.0297
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neutrophil (PMN) influx in the acute inflammatory response is associated with a local increase in vascular permeability and oedema, Vascular endothelial growth factor (VEGF), a growth factor known to have potent vascular permeability-enhancing properties in addition to being an endothelial cell mitogen and a chemo-attractant for mononuclear cells, has previously been shown to be expressed by mononuclear cells and platelets, though PMN VEGF expression has not been reported. PMNs isolated from healthy adult volunteers (n = 16) were incubated for 4 h at 37 degrees C in the presence of tumour necrosis factor alpha (TNF-alpha) (5 ng/ml) and serum opsonized zymozan (SOZ) (500 mu g/ml). Supernatant VEGF levels were measured using a sandwich antibody capture immune-assay. Median (interquartile range) VEGF levels were significantly increased in PMN supernatants following stimulation with both TNF-alpha [347 pg/ml (264-385 pg/ml)] and SOZ [506 pg/ml (407-593 pg/ml)] compared with control values [78 pg/ml (78-87 pg/ml)]. Time course experiments with SOZ stimulated PMNs showed that the majority of VEGF production occurred within the first hour (Ih mean VEGF level 318 pg/ml, 4 h mean VEGF level 451 pg/ml), RT-PCR studies showed that PMNs express mRNA for the two common VEGF splice variants, VEGF(121) and VEGF(165). PMN VEGF production may be central to the classic acute phase response to injury and the chemo-attraction of other leukocytes to the source of injury. (C) 1998 Academic Press Limited.
引用
收藏
页码:254 / 257
页数:4
相关论文
共 50 条
  • [41] Cyclosporine toxicity and vascular endothelial growth factor (VEGF).
    Kubisz, Peter
    Grandtnerova, Barbara
    Laca, Ludovit
    Stasko, Jan
    BLOOD, 2006, 108 (11) : 58B - 58B
  • [42] Vascular endothelial growth factor (VEGF) expression in plasmacytoma
    Paydas, S
    Zorludemir, S
    Baslamisli, F
    Tuncer, I
    LEUKEMIA & LYMPHOMA, 2002, 43 (01) : 139 - 143
  • [43] Vascular Endothelial Growth Factor (VEGF) in Autoimmune Diseases
    JozÉlio Freire Carvalho
    Miri Blank
    Yehuda Shoenfeld
    Journal of Clinical Immunology, 2007, 27 : 246 - 256
  • [44] Vascular endothelial growth factor (VEGF) in autoimmune diseases
    Freire Carvalho, Jozelio
    Blank, Miri
    Shoenfeld, Yehuda
    JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (03) : 246 - 256
  • [45] Vascular endothelial growth factor (VEGF) and its receptors
    Neufeld, G
    Cohen, T
    Gengrinovitch, S
    Poltorak, Z
    FASEB JOURNAL, 1999, 13 (01): : 9 - 22
  • [46] Vascular endothelial growth factor (VEGF) in ankylosing spondylitis
    Duftner, C
    Dulak, J
    Goldberger, C
    Weidlinger, F
    Falkenbach, A
    Schirmer, M
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 239 - 239
  • [47] The neuroprotective function of vascular endothelial growth factor (VEGF)
    Góra-Kupilas, K
    Josko, J
    FOLIA NEUROPATHOLOGICA, 2005, 43 (01) : 31 - 39
  • [48] Vascular Endothelial Growth Factor (VEGF) and Prostate Pathology
    Botelho, Francisco
    Pina, Francisco
    Silva, Pedro
    Figueiredo, Gabriela
    Cruz, Francisco
    Lunet, Nuno
    INTERNATIONAL BRAZ J UROL, 2010, 36 (04): : 430 - 437
  • [49] Vascular endothelial growth factor (VEGF): Plasma is the place to be
    Wynendaele, W
    Derua, R
    Hoylaerts, MF
    Pawinski, A
    Waelkens, E
    de Bruijn, EA
    Merlevede, W
    Paridaens, R
    van Oosterom, AT
    ANNALS OF ONCOLOGY, 1998, 9 : 122 - 122
  • [50] Vascular Endothelial Growth Factor (VEGF) in Neurodevelopmental Disorders
    Howell K.R.
    Armstrong J.
    Current Behavioral Neuroscience Reports, 2017, 4 (4) : 299 - 308